Published in Glycobiology on September 01, 2011
Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 2.09
Siglec receptors impact mammalian lifespan by modulating oxidative stress. Elife (2015) 1.20
Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline. Proc Natl Acad Sci U S A (2015) 1.16
Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLoS Pathog (2014) 1.11
Glycan evolution in response to collaboration, conflict, and constraint. J Biol Chem (2013) 1.10
Specific inactivation of two immunomodulatory SIGLEC genes during human evolution. Proc Natl Acad Sci U S A (2012) 1.06
Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. J Exp Med (2014) 1.05
Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J (2013) 1.01
Leukocyte inflammatory responses provoked by pneumococcal sialidase. MBio (2012) 0.98
The interplay between Siglecs and sialylated pathogens. Glycobiology (2014) 0.96
Infection, inflammation and host carbohydrates: a Glyco-Evasion Hypothesis. Glycobiology (2012) 0.95
Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors. Immunobiology (2014) 0.94
Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci (2013) 0.94
Are Platelets Cells? And if Yes, are They Immune Cells? Front Immunol (2015) 0.92
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci U S A (2014) 0.91
Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc. Immunogenetics (2014) 0.89
Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst. J Neurosci (2013) 0.89
The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors. Front Immunol (2015) 0.88
Global comparisons of lectin-glycan interactions using a database of analyzed glycan array data. Mol Cell Proteomics (2013) 0.87
Sialic acid: a sweet swing between mammalian host and Trypanosoma cruzi. Front Immunol (2012) 0.87
Evolution of siglec-11 and siglec-16 genes in hominins. Mol Biol Evol (2012) 0.86
Host cell polarity proteins participate in innate immunity to Pseudomonas aeruginosa infection. Cell Host Microbe (2014) 0.86
Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation. Front Immunol (2015) 0.84
Post-conversion sialylation of prions in lymphoid tissues. Proc Natl Acad Sci U S A (2015) 0.83
The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL. PLoS One (2015) 0.83
Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14. EMBO J (2015) 0.83
Sugar-coated sperm: Unraveling the functions of the mammalian sperm glycocalyx. Mol Reprod Dev (2015) 0.81
Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. J Biol Chem (2014) 0.80
Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo. Infect Immun (2015) 0.80
Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation. Sci Rep (2016) 0.79
Sialic acids and autoimmune disease. Immunol Rev (2016) 0.78
Evidence of involvement of the mannose receptor in the internalization of Streptococcus pneumoniae by Schwann cells. BMC Microbiol (2014) 0.77
Notable Aspects of Glycan-Protein Interactions. Biomolecules (2015) 0.77
Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. J Mol Med (Berl) (2015) 0.76
Sialylation of neurites inhibits complement-mediated macrophage removal in a human macrophage-neuron Co-Culture System. Glia (2015) 0.76
Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Matrix Biol (2016) 0.76
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules (2016) 0.76
SAMP-ending down sepsis. Ann Transl Med (2016) 0.75
Glycomics: revealing the dynamic ecology and evolution of sugar molecules. J Proteomics (2015) 0.75
Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol (2016) 0.75
The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression. Front Oncol (2016) 0.75
Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. EMBO J (2017) 0.75
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina. EMBO Mol Med (2017) 0.75
Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci (2016) 0.75
A Mouse Model for Dietary Xenosialitis: ANTIBODIES TO XENOGLYCAN CAN REDUCE FERTILITY. J Biol Chem (2016) 0.75
Production, purification and crystallization of a trans-sialidase from Trypanosoma vivax. Acta Crystallogr F Struct Biol Commun (2015) 0.75
Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation. Blood (2017) 0.75
The danger model: a renewed sense of self. Science (2002) 13.85
The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 12.89
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol (2011) 5.73
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science (2009) 5.00
Resolution of lung inflammation by CD44. Science (2002) 4.09
TLRs and innate immunity. Blood (2008) 3.96
Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev (2004) 3.11
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem (2004) 2.81
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol (2010) 2.71
Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol (2004) 2.62
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J (2006) 2.41
The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol (1998) 2.31
Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci U S A (2010) 2.30
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun (2008) 2.29
Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem (2004) 2.24
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood (2009) 2.24
Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood (2007) 2.20
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest (2010) 2.07
NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem (2009) 1.91
Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat Biotechnol (2011) 1.91
The acquired immune system: a vantage from beneath. Immunity (2004) 1.64
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc Natl Acad Sci U S A (2011) 1.58
Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol (2000) 1.43
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology (2010) 1.37
Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem (2007) 1.36
The genetic and evolutionary balances in human NK cell receptor diversity. Semin Immunol (2008) 1.35
Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure. Proc Natl Acad Sci U S A (2009) 1.34
Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J (2006) 1.32
Microbial glycosaminoglycan glycosyltransferases. Glycobiology (2002) 1.29
Human-specific evolution of sialic acid targets: explaining the malignant malaria mystery? Proc Natl Acad Sci U S A (2009) 1.23
Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol (2009) 1.16
"Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol Immunol (2003) 1.08
Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition. FEBS Lett (2009) 1.08
Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs. Am J Respir Cell Mol Biol (2010) 1.05
ABO blood group glycans modulate sialic acid recognition on erythrocytes. Blood (2009) 0.96
Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma. Eur J Hum Genet (2010) 0.93
Natural ligands for CD33-related Siglecs? Glycobiology (2009) 0.89
Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7.98
Intra- and interspecific variation in primate gene expression patterns. Science (2002) 7.92
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev (2002) 4.61
Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A (2003) 3.13
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A (2002) 3.10
Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest (2007) 2.64
Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid. Proc Natl Acad Sci U S A (2005) 2.53
Sequencing the chimpanzee genome: insights into human evolution and disease. Nat Rev Genet (2003) 2.41
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood (2009) 2.24
Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood (2007) 2.20
Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem (2004) 2.17
Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature (2008) 2.11
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature (2010) 2.10
Human-specific regulation of alpha 2-6-linked sialic acids. J Biol Chem (2003) 2.10
Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci U S A (2002) 2.00
Advances in the biology and chemistry of sialic acids. ACS Chem Biol (2010) 1.96
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A (2004) 1.93
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest (2002) 1.91
N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol (2007) 1.87
Loss of Siglec expression on T lymphocytes during human evolution. Proc Natl Acad Sci U S A (2006) 1.75
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest (2003) 1.73
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology (2008) 1.68
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc Natl Acad Sci U S A (2008) 1.62
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol (2006) 1.57
Sexual selection by female immunity against paternal antigens can fix loss of function alleles. Proc Natl Acad Sci U S A (2011) 1.56
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A (2002) 1.55
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol (2010) 1.53
Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood (2007) 1.52
The sialome--far more than the sum of its parts. OMICS (2010) 1.50
Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology (2008) 1.47
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med (2008) 1.45
Evolution of genetic and genomic features unique to the human lineage. Nat Rev Genet (2012) 1.44
Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J Immunol (2009) 1.43
Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. J Biol Chem (2002) 1.42
Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost (2002) 1.39
L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res (2006) 1.37
Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc Natl Acad Sci U S A (2004) 1.36
Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure. Proc Natl Acad Sci U S A (2009) 1.34
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med (2009) 1.34
Fixation of the human-specific CMP-N-acetylneuraminic acid hydroxylase pseudogene and implications of haplotype diversity for human evolution. Genetics (2005) 1.34
Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Proc Natl Acad Sci U S A (2004) 1.33
A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med (2010) 1.33
Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J (2006) 1.32
Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol (2009) 1.31
Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation (2011) 1.27
alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res (2008) 1.27
A human-specific gene in microglia. Science (2005) 1.26
Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol (2005) 1.26
Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol (2011) 1.25
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res (2011) 1.25
Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products. PLoS One (2009) 1.24
Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13. Respir Res (2010) 1.24
Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem (2002) 1.20
Combinatorial chemoenzymatic synthesis and high-throughput screening of sialosides. ACS Chem Biol (2008) 1.20
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev (2012) 1.17
Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium. Blood (2009) 1.16
Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2011) 1.15
Human-specific expression of Siglec-6 in the placenta. Glycobiology (2007) 1.15
Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med (2010) 1.15
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thromb Res (2007) 1.15
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity. Clin Cancer Res (2005) 1.14
Effects of sialic acid substitutions on recognition by Sambucus nigra agglutinin and Maackia amurensis hemagglutinin. Anal Biochem (2002) 1.14
The ethics of research on great apes. Nature (2005) 1.11
Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays. J Biol Chem (2012) 1.07
The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters. J Biol Chem (2006) 1.07
Specific inactivation of two immunomodulatory SIGLEC genes during human evolution. Proc Natl Acad Sci U S A (2012) 1.06
NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus. J Biol Chem (2007) 1.06
Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol (2010) 1.04
Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"? Cancer Res (2006) 1.04
CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol (2003) 1.03
Human uniqueness and the denial of death. Nature (2009) 1.02
Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J (2013) 1.01
Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood (2011) 1.00
Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J Biol Chem (2012) 0.99
System-wide genomic and biochemical comparisons of sialic acid biology among primates and rodents: Evidence for two modes of rapid evolution. J Biol Chem (2006) 0.99
Leukocyte inflammatory responses provoked by pneumococcal sialidase. MBio (2012) 0.98
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood (2002) 0.97
Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis. Glycobiology (2004) 0.97
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol (2013) 0.96
ABO blood group glycans modulate sialic acid recognition on erythrocytes. Blood (2009) 0.96
Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest (2016) 0.95
A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor. Glycobiology (2003) 0.95
Hyaluronan digestion controls DC migration from the skin. J Clin Invest (2014) 0.95
Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact. Glycobiology (2009) 0.94
Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci (2013) 0.94
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One (2013) 0.94
Efficient chemoenzymatic synthesis of biotinylated human serum albumin-sialoglycoside conjugates containing O-acetylated sialic acids. Org Biomol Chem (2007) 0.93
Class assignment of sequence-unrelated members of enzyme superfamilies by activity-based protein profiling. Angew Chem Int Ed Engl (2005) 0.92
O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence. Biochem J (2010) 0.91
A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome. Kidney Int (2009) 0.91
Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A (2014) 0.91
Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice. J Immunol (2013) 0.91
SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas. J Biol Chem (2011) 0.91
Generation of mice deficient for macrophage galactose- and N-acetylgalactosamine-specific lectin: limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins. Mol Cell Biol (2002) 0.90
9-O-acetylation of exogenously added ganglioside GD3. The GD3 molecule induces its own O-acetylation machinery. J Biol Chem (2006) 0.89
Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid. J Biol Chem (2012) 0.88
Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency. FASEB J (2011) 0.88
Human-specific evolutionary changes in the biology of siglecs. Adv Exp Med Biol (2015) 0.88
Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs. Exp Hematol (2006) 0.87